What is the current Vaccine Packaging Market size?

The Vaccine Packaging Market is projected to register a CAGR of 10.62% during the forecast period (2024-2029) Read More

Who are the key players in Vaccine Packaging Market?

Gerresheimer AG, Nipro Corporation, Piramal Glass Private Limited, Catalent, Inc. and Schott AG are the major companies operating in the Vaccine Packaging Market. Read More

Which is the fastest growing region in Vaccine Packaging Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Vaccine Packaging Market?

In 2024, the Europe accounts for the largest market share in Vaccine Packaging Market. Read More

What years does this Vaccine Packaging Market cover?

The report covers the Vaccine Packaging Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Vaccine Packaging Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Vaccine Packaging Market Size & Share Analysis - Industry Research Report

Vaccine Packaging Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Vaccine Packaging Market is Segmented by Type (Glass Vials, Prefillable Syringes, Vial Closures, Secondary Vaccine Packaging) and Geography (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa). The market sizes and forecasts are provided in terms of value (USD million) for all the above segments.

Vaccine Packaging Industry Overview

The vaccine packaging market is highly competitive due to the strong presence of major players worldwide. The market is moderately considerably concentrated owing to the strict requirements for quality of packaging as well as the presence of large market players in the industry. Major market players are adopting strategies like product innovation, mergers and acquisitions, and expansion to expand their reach and increase their production capabilities.

July 2022: Gerresheimer, a manufacturer of injection vials for vaccines, announced to increase the glass vial production at its Wertheim, Germany, facility as well as at two additional locations in China and the United States. To increase vial capacity by 150 million per year, the company has planned to invest in production in Wertheim.
March 2022: The Biomedical Advanced Research and Development Authority (BARDA) agreed to fund Stevanato Group up to USD 95 million through an agreement that was entered into by OMPI of America Inc., a subsidiary of Stevanato Group. Stevanato Group will increase its intended manufacturing capacity in Fishers, Indiana, for both standard and EZ-Fill vials, as per the agreement.